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Abstract:  Fish consumption is a potential route of human exposure to the hepatotoxic 
microcystins, especially in lakes and reservoirs that routinely experience significant toxic 
Microcystis blooms. Understanding the rates of uptake and elimination for microcystins as 
well as the transfer efficiency into tissues of consumers are important for determining the 
potential for microcystins to be transferred up the food web and for predicting potential 
human health impacts. The main objective of this work was to conduct laboratory 
experiments to investigate the kinetics of toxin accumulation in fish tissue. An oral route of 
exposure was employed in this study, in which juvenile yellow perch (Perca flavescens) 
were given a single oral dose of 5 or 20 μg of microcystin-LR (MC-LR) via food and 
accumulation in the muscle, liver, and tank water were measured over 24 h. Peak 
concentrations of the water soluble fraction of microcystin were generally observed 8–10 h 
after dosing in the liver and after 12–16 h in the muscle, with a rapid decline in both tissues 
by 24 h. Up to 99% of the total recoverable (i.e., unbound) microcystin was measured in 
the tank water by 16 h after exposure. The relatively rapid uptake and elimination of the 
unbound fraction of microcystin in the liver and muscle of juvenile yellow perch within  
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24 h of exposure indicates that fish consumption may not be a major route of human 
exposure to microcystin, particularly in the Great Lakes.  
Keywords: microcystin; accumulation; kinetics; yellow perch; Microcystis; Great Lakes; 
fish consumption 
 
1. Introduction  
Cyanobacterial harmful algal blooms (HABs) are increasingly prevalent in the Great Lakes as well 
as smaller inland lakes and reservoirs throughout the world, fueled by eutrophication and perhaps 
increasing global temperatures [1,2]. The proliferation of HABs has significant ecological 
consequences, including contributing to hypoxia and food web disruption [3]. In addition, there are 
also significant concerns about the direct impacts of cyanotoxins on human and animal health. In 
shallow, warm, nutrient enriched regions of the North American Great Lakes, such as the western 
basin of Lake Erie, Saginaw Bay (Lake Huron), and Green Bay (Lake Michigan), summer HAB 
blooms dominated by Microcystis are common and produce the hepatotoxic microcystins [4,5]. 
Microcystins are a group of cyclic peptide toxins whose variants differ in the L-amino acid residues  
2 (X) and 4 (Z) [6]. The most commonly occurring variant, as well as one of the most toxic, is 
microcystin-LR (MC-LR) and the World Health Organization has established a provisional guideline 
for MC-LR in finished drinking water of 1 µg L
−1 [7]. Microcystins inhibit serine/theonine protein 
phosphatases [6] which can cause disintegration of the liver structure, cellular damage to hepatocytes, 
liver necrosis, and internal hemorrhage in the liver [8]. Symptoms of acute microcystin exposure in 
humans has included gastroenteritis (vomiting, diarrhea, abdominal cramping) and blistering around 
the mouth and pneumonia during incidences of immersion [9–11].  
Less studied are the potential consequences of low-level chronic exposure, which could result in 
liver disease, promotion of carcinogenic tumors in animal models [12] and is perhaps linked to liver 
and colon cancer [13,14]. Chronic exposure of humans to microcystins has been considered primarily 
through drinking water, which has been correlated with increased liver damage in local residents [9,13] 
and recreational contact in waters experiencing Microcystis blooms [15]. Another potential route of 
human exposure that has not been widely investigated is fish consumption. Recreational and 
commercial fishing is particularly important in the Great Lakes, including in areas with frequent and 
dense Microcystis blooms. Fish can be a significant part of the local diet and it is not well known the 
degree to which microcystins accumulate in edible muscle tissue of popular Great Lakes recreational 
fish (e.g., yellow perch, walleye, and bluegill). Microcystins are highly stable compounds and toxicity 
is not reduced by boiling or cooking [16]. More data on the timing and concentrations at which 
microcystins accumulate in fish muscle will provide a better understanding of the potential for fish to 
be a route of chronic exposure of humans to cyanotoxins.  
It is generally agreed that the major route in which microcystins are taken up by fish is through the 
gastrointestinal tract and therefore primarily via diet [17]. There is some debate in the literature about 
the potential for microcystins to pass through fish gills. Some studies observed bioaccumulation of 
microcystins on gills and damage to gill tissue by MC-LR [18,19], while others maintain the Mar. Drugs 2011, 9  
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microcystin compounds are too large to cross the gill membrane [20,21]. Phytoplanktivorous fish may 
take up toxic Microcystis cells directly from the water column [22], but likely many fish are exposed 
through their diet of zooplankton, benthic invertebrates, and fish [19,23]. The degree to which Microcystis 
cells pass through the fish gut and are excreted unabsorbed is also not well known. Carbis et al. [24] 
demonstrate mucus production in the intestine upon exposure to microcystins, which might block 
hepatatoxin uptake. However, it is clear that uptake of microcystins is not always completely blocked 
since fresh- and brackish-water fishes are known to accumulate cyanotoxins in tissues, including 
muscle, viscera, heart, intestine, gallbladder, spleen, gonad, brain and liver [23,25–29]. Most of the 
studies that assess uptake of microcystins in fish used intraperitoneal (IP) injection as the route of 
exposure. While useful in delivering a known dose of toxin, IP injection does not provide an 
environmentally realistic route of exposure to the fish and represents direct delivery of the toxin 
instead of the usual route through the intestines. Thus, the IP route may not provide an accurate 
assessment of the rates and locations of toxin accumulation in the fish. Other studies have measured 
microcystin concentrations in wild-caught fish inhabiting water bodies with cyanoblooms, including 
western Lake Erie [28,30]. An inherent difficulty in trying to correlate concentrations in fish tissue to 
lake concentrations of microcystins is the heterogeneity in exposure due the capacity of fish to swim in 
and out of Microcystis blooms, making the dose of microcystins received impossible to ascertain. 
Thus, while measurements of concentrations of microcystins in field-collected fish are useful in 
identifying whether this is a potential route for human exposure, it reveals less about the mechanism of 
accumulation and how rapidly the fish will eliminate the absorbed microcystins. This study used a 
single known oral dose of the most commonly occurring microcystin variant, MC-LR, in yellow perch 
to investigate the kinetics of toxin uptake and elimination in fish muscle and liver tissue over a short 
(24 h) time course. The goal of this study is to better understand whether fish consumption is a 
potential route of human exposure to microcystins. 
2. Results and Discussion  
2.1. Timing of MC-LR Accumulation in Yellow Perch 
The preliminary experiment that was used to select the appropriate time points for sampling fish 
after MC-LR exposure showed that after a dose of 5 µg·fish
−1, MC concentration in both the liver and 
muscle peaked at 8–10 h and returned to concentrations below 4 ng g
−1 MC within 24 h, remaining 
low through the end of the experiment at 240 h (unpublished data). This preliminary experiment 
suggested that a more detailed analysis of time points up through 24 h should be the focus of the 
dosing experiments, which resulted in an increased number of time points sampled between 0–24 h 
and no further sampling past 24 h in the remainder to the experiments, described below.  
Environmentally relevant doses were chosen for the experiments. Yellow perch less than 150 mm in 
size generally consume 1.31 g dry food per 100 g fish (wet weight) each day [31] and it is known from 
stomach content analysis by Wilson et al. [28] that early in the summer, juvenile yellow perch in 
western Lake Erie are eating predominantly benthic invertebrates (76%), followed by fish (18%) and 
zooplankton (7%). The total weight of food consumed was scaled to the average fish size in this 
experiment and partitioned based on this expected diet. Literature sources were used to identify some Mar. Drugs 2011, 9  
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minimum and maximum concentrations of microcystins commonly found in those groups via natural 
routes of exposure. Concentrations of microcystins ranged 1–30 µg g
−1 in benthic macroinvertebrates 
in Michigan lakes with Microcystis, 0.017–1.19 µg g
−1 in the muscle and liver of Lake Erie juvenile 
yellow perch and 0.2–1352 µg g
−1 in zooplankton (mostly Daphnia) [17,28]. Although these are 
approximations and the exact concentration of microcystins in each component of the diet is not 
known, particularly for chironomids which are a significant part of the diet at this life stage, daily 
exposure to microcystins for this size fish via an early summer diet during a toxic Microcystis bloom is 
estimated to be in the range of 1–25 µg for yellow perch.  
The dose of MC-LR given on each food pellet was confirmed by extraction and quantification by 
ELISA from spare pellets. The 5 µg MC-LR dose was actually 6.38 ± 0.58 µg and the 20 µg dose was 
19.70 ± 2.20 µg. The analytical error was determined by quantifying the recovery of a known 
concentration of MC-LR spiked into control tissue samples before extraction. The recovery of spiked 
MC-LR into muscle tissue was 89.3 ± 9.3% (n = 11) and from liver tissue was 77.0 ± 10.6% (n = 4). 
The liver and muscle MC data presented below have not been corrected for these recovery rates.  
Yellow perch of similar size were chosen for the experiments, but there was still variability in fish 
weight within and between experiments. Fish in the 5 µg experiment were 12.61 ± 4.80 g wet weight 
(range of 5 to 24.5 g) and in the 20 µg experiment were 17.62 ± 5.65 g wet weight (range of 9.6 to 
29.3 g) even though the lengths only varied by a factor of 2.1 for the 5 µg dose and 1.4 for the 20 µg 
dose. Thus, the condition of the fish may have been different even though they were from the same 
source. Fish of smaller size are known to have a higher metabolism and potentially higher 
concentrations of contaminant relative to similarly exposed fish of a larger size [32,33]; therefore the 
lack of uniform fish size may have increased the variability of MC concentrations between replicate 
fish. To control for this variability and better assess the impacts of time on MC accumulation in fish 
tissues, the lowest 5% of all fish in each experiment by weight were not included in the data analysis to 
determine peak periods of MC concentrations in the tissues. This was a total of three fish per 
experiment. In addition, one fish per experiment was rejected as an outlier based on both tissue and 
liver concentrations (Q-test, 95% confidence interval) [34].  
In all experiments, the concentration of MC in the fish liver was elevated by 4–6 h and   
peaked at 8–10 h after oral dosing. In the 5 µg experiment, there was a sharp increase at 8 h to  
86.58 ± 20.01 ng MC g
−1 dw (dry weight), followed by a significant decrease to less than 38 ng MC g
−1 dw 
by 12 h (Figure 1). In the 20 µg experiment, the MC concentration in the liver remained elevated at  
8–10 h, with a peak concentration of 93.19 ± 21.56 ng MC g
−1 dw, and then decreased to less than  
35 ng MC g
−1 dw by 12 h post-dosing (Figure 2). In both the 5 µg and 20 µg dose experiments, the 
concentration in the liver remained between 20–30 ng MC g
−1 dw through 21 h post-dosing. By 24 h, 
the liver MC concentration remained at 24.78 ± 22.04 ng MC g
−1 dw in the 5 µg experiment, but in  
the 20 µg dose decreased further to 7.27 ± 4.96 ng MC g
−1 dw. At 24 h, MC concentrations in the liver 
of control fish not dosed with MC was 9.03 ± 4.14 ng MC g
−1 dw for the 5 µg experiment and  
0.72 ± 0.54 ng MC g
−1 dw for the 20 µg experiment.  
Concentrations of MC in the fish muscle tissue peaked at 12 h after the fish was dosed in both the  
5 µg and 20 µg experiment. Concentrations were lower in the muscle than in the liver, with   
maximum concentrations of 41.38 ± 51.49 ng MC g
−1 dw in the 5 µg experiment (Figure 2) and  
30.35 ± 25.75 ng MC g
−1 dw in the 20 µg experiment (Figure 2). By 24 h post-dosing, the average  Mar. Drugs 2011, 9  
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MC concentrations in the 5 µg experiment (Figure 1) was 8.54 ± 2.58 ng MC g
−1 dw and   
2.74 ± 2.14 ng MC g
−1 dw for the 20 µg experiment (Figure 2). The muscle tissue of control fish at the 
24 h time point contained 0.08 ± 0.06 ng MC g
−1 dw for the 5 µg experiment (Figure 1) and   
1.81 ± 1.03 ng MC g
−1 dw in the 20 µg experiment (Figure 2). 
Figure 1. Concentrations of microcystin (ng microcystin per g dw fish tissue) in yellow 
perch liver and muscle tissue for time points 0–24 h after given a single oral dose of 5 µg 
MC-LR. Error is expressed as standard deviation of four replicate fish. 
 
Figure 2. Concentrations of microcystin (ng microcystin per g dw fish tissue) in yellow 
perch liver and muscle tissue for time points 0–24 h after given a single oral dose of 20 µg 
MC-LR. Error is expressed as standard deviation of four replicate fish. 
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Initial concentrations of MC were also higher in fish from the 5 µg experiment in comparison to the 
20 µg experiment. At the beginning of the experiment, before oral dosing, MC concentrations in the 
liver and muscle were 10.36 ± 11.75 and 0.38 ± 0.22 ng MC g
−1 dw, respectively, in the 5 µg 
experiment and 1.25 ± 0.76 and 0.21 ± 0.10 ng MC g
−1 dw in the 20 µg experiment. As a hepatotoxin 
targeting the liver, at least some portion of any measurable accumulation of MC in the fish organs 
would be expected in the liver tissue. In this study, an initial peak in MC concentrations was measured 
in the liver at 8–10 h followed by maximum MC accumulation in the muscle tissue at 12 h and a 
significant decrease in the concentration of unbound MC in both tissues by 24 h after exposure. The 
measurement of maximum MC concentrations in the liver that were as much as three times higher than 
those in the muscle also further supports the preferential accumulation of this toxin in the liver. 
Multiple field studies have documented the uptake of microcystins into the liver and muscle of 
planktivorous [22,23], omnivorous [18,19] and piscivorous fish [19] and lab studies using fish dosed 
through oral gavage or intraperitoneal (IP) injection [29,35–37] have confirmed the accumulation of 
microcystins in these organs. However, despite the useful data these studies have contributed, there 
still remains an incomplete understanding of the capacity of fish to accumulate and eliminate 
microcystins and the timing over which this occurs. This is in part due to the difficulty in determining 
the actual levels of exposure in field-caught fish and the lack of environmentally relevant modes of 
exposure in laboratory studies. While it is acknowledged that the current study also lacks some 
environmental relevance due to the use of purified toxin instead of microcystins delivered in the form 
of Microcystis cells, or other food source which has accumulated toxins by feeding or filtering, the 
advantage here is that a known dose of MC-LR is provided, eliminating variability associated with cell 
size, mucilage content, internal microcystin content or other matrix effects of Microcystis cells.  
The current study assessed the effect of a single dose, in contrast to many of the previous feeding 
studies in which fish were exposed to MC-LR over a multiple day period [38,39]. A single dose was 
chosen in order to better determine the timing of uptake into tissues. However, despite the differences 
in feeding frequency and experiment duration between this and other studies, the pattern of 
accumulation of microcystins in the liver first followed by the muscle is relatively consistent. In a  
15 day study in which juvenile tilapia were fed Microcystis cells daily containing concentrations   
of microcystins in a similar range to our 20 µg MC-LR dose, maximum liver concentrations of 
microcystins were observed on day 6 and maximum muscle concentrations on day 9 [38]. In a similar 
experiment, Smith and Haney [39] measured the accumulation and elimination of microcystins in 
pumpkinseed sunfish using a 1000 fold lower dose of microcystins given over 9 days via a 
zooplankton food source. Their first trial showed a similar pattern of accumulation with the maximum 
concentration of microcystins found in the liver at 2–4 days and in the muscle by day 4. However, the 
liver and muscle concentrations of microcystins did not show this clear pattern in their second trial, 
likely due to the high degree of variability measured in samples [39], which also highlights the 
heterogeneity in response between individual fish. Such heterogeneity among fish may be due to size, 
as observed in this study. 
Two different doses of MC-LR were administered in this study, but there was not a clear dose 
dependent accumulation detected. Maximum MC concentrations in both the liver and muscle tissues 
were similar in the 5 µg and 20 µg doses, as was the timing of accumulation and elimination of the 
toxin. While this could be due to the maximum capacity of the tissues to absorb the compound, there Mar. Drugs 2011, 9  
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were also a number of other confounding factors that may have impacted the measured MC 
concentrations. The presence of microcystins in the fish livers of the fish at the 0 h time point (before 
dosing) in the 5 µg experiment was evidence that the fish had previous exposure to microcystins in the 
fish farm from which they originated. Although the fish were held in microcystin-free water for 24–28 h 
before the start of the experiment, low levels of microcystins in the liver persisted, likely resulting in 
higher maximum MC concentrations than would have otherwise been measured. Additionally, the fish 
used in the 5 µg experiment were smaller on average than those used in the 20 µg experiment.   
A previous study [40] also observed that smaller fish have higher concentrations of microcystins than 
larger fish of the same species from the same lake. This difference in mass between dosing groups is 
potentially a main driving force in tissue concentrations of microcystins. A fish with more mass will 
require a greater accumulation of toxin to achieve a higher tissue concentration.  
As pointed out by Smith and Haney [39], the amount of microcystins that accumulate in fish may 
be determined by the route by which the fish is exposed. By 24 h of exposure, 80% of microcystins 
administered to pumpkinseed sunfish through a zooplankton diet was accumulated in a non-covalently 
bound form in the liver [39], while there was only approximately 1.7–10% absorption in the liver of 
MC-LR delivered to rainbow trout via gavage of toxic Microcystis cells [20,35], 5% absorption of 
MC-LR in the livers of yellow perch via an oral dose of MC-LR (this study) and 0.3% uptake in the 
liver when rainbow trout were orally gavaged with purified MC [36]. While the purified MC-LR 
would be expected to be more available for uptake than intracellular microcystin, it is also possible 
that much of the extracellular microcystin passes directly through the gut and is excreted without being 
taken up into the organ tissues. The peptide bonds linking D-amino acids in microcystins are not 
susceptible to normal hydrolytic enzymes, making these toxins resistant to digestion in the 
gastrointestinal tract [41,42]. The microcystin congener also impacts the degree to which microcystins 
are taken up by the fish. MC-LR alone was used as the microcystin dose in this study and there is an 
indication that MC-LR may be taken up to a much lower degree than microcystin-RR, another of the 
80+ variants of microcystin. Xie et al. [22] measured microcystins in silver carp (Hypophthalmichthys 
molitrix) fed toxic Microcystis viridis cells containing both MC-LR and -RR and, despite a high 
concentration of MC-RR in blood, liver, muscle and intestines, MC-LR was only found in the 
intestines of these fish. Comparing the ratio of MC-LR:RR in the seston vs. fish gut and feces 
suggested that the transport of MC-LR across the intestines is selectively inhibited, but MC-RR is able 
to cross through the intestines and into muscle tissues [22,43]. MC-RR was also measured in trace 
amounts in the brain of fish (Jenynsia multidentata) exposed to dissolved MC-RR in the laboratory, in 
addition to accumulating in the muscle at the end of the 24 h exposure [18]. Microcystis blooms 
generally contain multiple microcystin congeners so determining which are present may be important 
to assess potential toxicity and accumulation in fish. Therefore, despite the lower toxicity of MC-RR 
compared to many other microcystin variants, including MC-LR [44], its increased bioavailability may 
result in increased transport through trophic levels [22]. Though there is no evidence for 
biomagnification of microcystins in the food web, this toxin is vectorially transported to higher trophic 
levels [23]. Thus, the trophic level at which fish feed is also an important indicator of their potential 
tissue toxin concentration. There is no consensus in the literature about whether phytoplanktivorous or 
piscivorous fish generally have the highest levels of microcystins [19,23,45] and, even within these 
groups, there are likely significant species specific differences in metabolism of microcystins [30,46].  Mar. Drugs 2011, 9  
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2.2. Microcystin Elimination from Yellow Perch and Mass Balance 
Dissolved MC concentrations in the tank water increased with time. Microcystins were measurable 
in the tank water by 4 h after the fish were dosed in both the experiments and then steadily increased 
over the course of the experiment, with the highest concentrations measured at 24 h. In the 5 µg dose 
experiment, the average MC concentration in the tank water was 0.50 ± 0.37 µg at 12 h and 3.5 ± 1.2 µg 
by 24 h (Figure 3). Overall, concentrations were higher in the 20 µg dose experiment, with an average 
dissolved MC concentration in the tank water of 1.01 ± 0.11 µg at 12 h and 11.71 ± 1.2 µg by 24 h 
(Figure 3).  
Figure 3. Average microcystin concentration (µg MC) in fish tanks for time points 0–24 h 
after fish given a single oral dose of MC-LR (either 5 µg or 20 µg dose). This concentration 
represents the MC excreted by the fish, including both dissolved MC and any feces 
present. Error is expressed as standard deviation of four replicate fish tanks. 
 
In order to evaluate how the MC is partitioned, a rough mass balance was calculated by summing 
the total amount of MC in the fish muscle, liver, and tank water for each time point. Total MC 
measured in the fish and tank water is almost 3% of the initial 5 µg dose at 4 h, 10.5% by 12 h and a 
maximum of 70.3% accounted for by 24 h. In the 20 µg experiment, the total MC in fish liver, muscle 
and tank water combined was less than 1% of the initial dose at 4 h, less than 10% through 16 h and 
was 58.6% of the initial dose by 24 h (Table 1). Microcystins in the liver and muscle tissues never 
exceeded 0.3% of the total initial dose.  
Table 1. Percent of total microcystin dose measured at selected time points. 
Time point 
(h) 
5 µg  20 µg 
Muscle  Liver Tank  Muscle Liver Tank 
4  0.01 0.04 2.65 0.01 0.01 0.27 
8  0.03 0.05 3.41 0.03 0.03 1.27 
10  0.16 0.04 3.76 0.04 0.05 3.21 
12  0.29 0.09  10.10  0.10 0.08 5.04 
16  0.22 0.03  47.02  0.02 0.01 9.19 
24  0.07  0.02 70.17 0.01  0.01 58.56 
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Microcystin concentrations in the digestive track were not measured in this study, so it is not known 
what percentage of the total MC-LR dose passed through the gut unabsorbed compared to the 
percentage taken up by the tissues and subsequently detoxified and excreted within 24 h. To find out 
how quickly unabsorbed MC-LR might be expected to pass through the fish gut, an evacuation rate 
model was used. This model predicts the digestion of food pellets under given temperatures and fish 
sizes [31]. For the conditions of this experiment (20 °C, 15 g fish, 1 g food pellet), this model predicts 
that by 24 h at least 90% of the food pellet would have been excreted, thus suggesting that at least 90% 
of the MC-LR not taken up into fish tissue would have been passed through the gut without being 
absorbed by the end of the experiment. This rapid passage of food through the gut based on the 
digestion model suggests a relatively low accumulation efficiency for MC from food into the fish 
tissues. The peak concentrations observed with a single exposure were somewhat lower than the 
average liver concentration for field collected perch but much greater for muscle tissue than found in 
the field [28]. However, the rapid elimination rate from the tissue is independent of the uptake once 
exposure has ceased (e.g., the end of the ingestion of contaminated prey).  
Even given this rapid passage of food, and potentially associated MC, through the gut, there was 
still at least 30% of the initial MC-LR dose that was unaccounted for in the muscle, liver and tank 
water by the end of this experiment. A small percentage of this dose may be found in bile or other 
organs, including the heart, gonads, and stomach, but the literature suggests this is minimal [17,47,48]. 
A more significant percentage of the unaccounted fraction of the MC-LR dose is likely bound 
covalently and irreversibly to protein phosphatase 1 and 2A. The solvent extraction used in this study 
will not reverse the covalent bonds that can be formed between the MC-LR and the protein phosphatase 
enzyme active site and thus is only a measure of the unbound MC fraction, which may underestimate 
the true toxin load to the tissues (John Berry, Florida International University, pers. comm.). Previous 
studies have shown that as little as 24% of the total microcystins could be extracted from Atlantic 
salmon liver [49].  
The degree to which microcystins covalently bound to fish tissue is biologically available to higher 
trophic levels, including human consumers, is unknown [23,42]. However, it is likely that the unbound 
fraction is more readily available for trophic transfer. Of the total recoverable (i.e., unbound fraction) 
of MC measured in fish tissues and tank water in this experiment, the amount distributed in the muscle 
and liver tissues is not more than 4.1% at any given time point. A very high percentage of the 
recovered MC was in the tank water fraction, which also included any feces that might have been 
present. For both doses, from 15 h through the end of the experiment, the MC in the tank water 
comprised >99% of the total unbound MC. This large percentage of the unbound MC found in the tank 
water by 24 h after exposure to a single oral dose indicates that human exposure to microcystin via 
consumption of yellow perch is reduced as long as just the muscle tissue is being consumed. Since in 
many cases fish are only exposed to cyanotoxins intermittently while swimming through patchy blooms, 
there may be sufficient opportunity for elimination before being caught for human consumption. In 
addition to the decline in measurable microcystins in the liver and muscle by 24 h after exposure, the 
hepatic effects on fish are short term and serum biochemistry and hepatocyte morphology return to 
normal within 30 days of removal from exposure [24,37]. However, in small lakes with persistent toxic 
blooms, regular exposure may increase the probability of microcystins being present in the tissues of 
resident fish at the time they are caught for consumption. In a study on wild caught yellow perch in Mar. Drugs 2011, 9  
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western Lake Erie, which experiences regular summertime blooms of Microcystis, maximum 
concentrations of microcystins of 4.02 ng g dw
−1 in the muscle tissue were measured over the course 
of the bloom season [28], which is 8.6 times lower than the maximum muscle MC concentrations 
measured in this study. The maximum concentrations of microcystins measured in the liver of these 
wild caught fish was 12.7 times higher than in this experiment (1182 ng·g·dw
−1), suggesting that the 
lower toxin load in the muscle tissue was not solely due to a lower absorption of microcystins. There 
are many other commercially and recreationally important fish in the Great Lakes and a recent study 
has measured higher concentrations of microcystins in the muscle of wild caught fish belonging to 
these groups, particularly walleye, white bass, and smallmouth bass from Lake Erie (maximum 
concentrations of 43.6 ng·g·wet weight
−1) and alewives and northern pike from the Bay of Quinte, 
Lake Ontario (maximum concentrations of 37.5 ng·g·wet weight
−1) [40]. Naturally, the amount of 
microcystins that fish will be exposed to in their natural environment will vary greatly with bloom 
dynamics and toxicity, frequency and duration of exposure, fish size and diet, timing and frequency of 
feeding, food availability, life history, etc.  
2.3. Kinetics of MC Uptake 
The data were difficult to kinetically model in the sense that they were extremely variable   
(Figures 1 and 2). The variability could have been due to several sources of uncertainty. First, an 
examination of analytical variation yielded a relative percent difference for muscle tissue, measured in 
duplicate, of 41.1 ± 36.6% for the 5 µg dose and 60.5 ± 37.7% for the 20 µg dose. While this analytical 
variation appears to be large, it was not sufficient to account for most of the variation in the observed 
data, which were up to ten-fold or more different among tissue concentrations of different fish sampled 
after the same length of exposure (Figures 1 and 2). This variation appears to in part be due to 
differences in fish size, with smaller fish exhibiting greater tissue concentrations after the same length 
of exposure.  
As a result of the above variations in concentration, the fit to the data for the two tissues were not as 
robust as preferred but do provide some insight into the rate processes for microcystin in these fish. 
First, the elimination is relatively rapid with an apparent elimination half-life (elimination t0.5) calculated 
from ke in the range of 3.3 to 7.8 h for muscle (Table 2). Given this, the fish would be expected to 
eliminate 95% of the accumulated MC from muscle in 14.5 to 33.5 h (elimination t0.05). The elimination 
half-life for MC in the liver was calculated to be 10.5 h, with 95% elimination from the fish occurring 
within 46 h. The elimination modeled in this study does not specify mechanism but includes actual 
loss from the tissue as well as biotransformation to an unextractable or unmeasurable form. 
The loss rates for the exposure dose are the rates at which exposure of the fish to the initial dose 
decreases as the MC is taken up into the fish tissue or eliminated without being absorbed and no longer 
can serve as a source of exposure. These apparent loss rates for the exposure dose are similar between 
dose levels but different between tissues. The apparent loss of exposure was modeled as a faster (larger 
dose loss rate, λ) for the liver than for the muscle, meaning the period of time in which the liver was 
exposed to MC was shorter than the period of time the muscle was exposed. Microcystin-LR exposure 
in the liver has a shorter half-life (exposure t0.5) (2.3–4.5 h) compared to the muscle (14.8–16 h) due to 
the lower loss rate for exposure in the muscle. This suggests that 95% of the exposure to the initial Mar. Drugs 2011, 9  
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dose (exposure t0.05) is complete by 9.9–19.3 h in the liver but not until 63.7–69.2 h in the muscle 
(Table 2). This supports our approach of determining the elimination rate constant as a simple first 
order model since uptake would have been low and likely insignificant by 10 to 12 h, considering the 
very small size of the uptake rate constants.  
Table 2. Kinetic parameter estimates for MC in yellow perch for each tissue at each 
exposure dose. ke is the elimination rate constant (h
−1),  ku is the uptake rate constant 
(g
−1·h
−1), λ is the loss rate for the dose (h
−1), elimination t0.5 is the half-life in each tissue, 
elimination t0.05 is the time for 95% elimination from the tissue (both elimination values 
calculated based on ke), exposure t0.5 is the half-life for exposure in each tissue, exposure 
t0.05 is the time for completion of 95% of the exposure (both exposure values calculated 
based on λ). 
Tissue/ 
Concentration 
ke 
(h
−1) 
ke 
r
2 
ku 
(g
−1h
−1) 
λ 
(h
−1) 
ku, λ 
r
2 
Elimination Exposure 
t0.5 
(h) 
t0.05 
(h) 
t0.5 
(h) 
t0.05 
(h) 
5 µg–Muscle  0.089 ± 0.058  0.55  0.00058 ± 0.00024  0.047 ± 0.051  0.41  7.8  33.5  14.8  63.7 
20 µg–Muscle  0.21 ± 0.07  0.62  0.00017 ± 0.000059  0.043 ± 0.035  0.44  3.3  14.5  16.0  69.2 
5 µg–Liver  0.066 ± 0.037  0.71  0.0019 ± 0.0006  0.155 ± 0.069  0.59  10.5  45.4  4.5  19.3 
20 µg–Liver  0.066 ± 0.029  0.81  0.0016 ± 0.0007  0.30 ± 0.15  0.55  10.5  45.8  2.3  9.9 
The uptake rate constants (ku) calculated in this model are somewhat different from more familiar 
values that are often calculated, such as clearance coefficients. The uptake rate constants indicate the 
fraction of the dose accumulated by the respective fish tissue each hour. As with the exposure 
constants, the uptake rate constants are similar between doses but different between tissues. The uptake 
of the liver is relatively fast, about ten times faster than for the muscle. These differences reflect the 
much greater concentrations found in the liver compared to the muscle and further support the idea that 
uptake occurs first into the liver with some later redistribution to the muscle. Despite the much lower 
concentration in the muscle, the total amount of MC found in the muscle is often greater than that 
found in the liver because of the relative size of the two organs. 
Higher concentrations of MC in the liver compared to the muscle tissue has been observed in  
many other studies as well, regardless of dosing mechanism or species [29,38,45,47,50]. Selective 
uptake of microcystins into hepatocytes occurs via active transport, resulting in organ specificity of 
accumulation [51]. Reasons for these differences in liver and muscle MC concentrations are 
demonstrated by the kinetics model developed in this study. The first order model used shows the 
rapid uptake and elimination of MC from the liver and much slower rates in the muscle. This is 
consistent with overall higher MC concentrations measured in the liver as well as the maximum liver 
concentrations proceeding maximum muscle concentrations in time. This leads to the hypothesis that 
the initial uptake of MC is into the liver and then partially redistributed into the muscle, prolonging the 
exposure period for the muscle.  
The kinetics of MC uptake and loss were similar regardless of dose, potentially driven by the ability 
of MC to cross membranes [22]. Without an increase in MC uptake rate with increased dose, total 
concentrations of MC in fish with a larger tissue mass would be overall lower than in smaller fish. 
Another toxicokinetic model, which was developed for accumulation of microcystins in the nile tilapia Mar. Drugs 2011, 9  
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Oreochromis niloticus, showed that for lower doses of microcystins, there may be a greater dose 
dependent effect [45]. In this model, at doses of microcystins below 0.15 µg·MC·fish
−1·day
−1, 
accumulation in the liver was not accompanied by elimination, resulting in liver concentrations as high 
as 51% of the dose. At intermediate concentrations (0.15–2.5 µg·MC·fish
−1·day
−1), increasing available 
microcystins did not result in increased liver concentrations, due to an increased capacity for 
elimination. This model predicts that at concentrations greater than 2.5 µg·MC·fish
−1·day
−1, a saturation 
point is reached for nile tilapia and there is again an increase in liver microcystin concentrations with 
increasing dose [45]. Thus the lack of dose response for tissue concentrations in the current experiment 
may be an indication that doses of 5–20 µg MC fish
−1 may be in the intermediate phase of accumulation 
for yellow perch of this size and that higher or lower concentrations of MC are necessary to see a  
dose response.  
2.4. Potential Impacts of Microcystins Human Health via Fish Consumption 
The variability in exposure and the lack of data on the biological availability of the covalently 
bound microcystins in fish tissue makes it difficult to discern the potential risk of microcystins to 
human health through fish consumption [23,42]. There is circumstantial evidence of exposure to 
microcystins and toxicity to humans via consumption of contaminated fish [6] and the WHO 
recommended total daily intake (TDI) of 0.04 μg per kg bodyweight
 per day can be applied to 
concentrations of microcystins in fish to determine acceptable fish tissue concentrations. Populations 
that are in the greatest danger of health risks are those for which fish comprise a high percentage of the 
diet. Average consumption of sport fish by anglers and their families in the Great Lakes basin is 
estimated at 40 g fish·day
−1, which is higher than the US national average fish consumption of   
6.5 g day
−1 [52–54]. Of greater concern are native tribal members for whom fish is much larger 
proportion of their diet, estimated to be an average of 190 g day
−1 and as much as 328 g day
−1 [55]. 
Using the WHO recommended TDI for a 70 kg adult and these average consumption rates, the 
maximum recommended fish muscle concentration would be 70 ng MC g fish
−1 for the average Great 
Lakes angler, 14.7 ng MC g
−1 for tribal members and 8.5 ng MC g
−1 for very high fish consumers to 
prevent potential human illness. A recent draft document from EPA (NCEA-C-1765) used data from 
Heinze [56] to suggest a lower recommended limit for chronic exposure of 0.003 μg kg
−1 per day, which 
would lower the maximum recommended fish levels of microcystins to 5.3, 1.1, and 0.6 ng MC g
−1 for 
Great Lake anglers, tribal members and very high fish consumers, respectively. These recommended 
microcystin concentration would be even lower for children, elderly, or sensitive individuals.  
The uptake and elimination experiments described in this manuscript suggest that juvenile yellow 
perch exposed to environmentally relevant doses of microcystins have the capacity to eliminate the 
unbound fraction in the muscle tissue from a maximum of 18.7 ng g
−1 ww down to 0.6 ng g
−1 ww 
(expressed as wet weight to more accurately compare to the weight of a fish meal instead of dry weight 
as reported in the results) by 24 h after exposure. These data suggest that during periods of significant 
microcystin-producing blooms, consumers for whom fish is a substantial part of their diet could 
receive a dose that exceeds the WHO TDI. If the more conservative EPA guidelines were adopted, the 
recommended limits for chronic microcystins would be exceeded even by the average Great Lakes fish 
consumer during a toxic bloom. However, the evidence of rapid elimination presented here suggests Mar. Drugs 2011, 9  
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that during non-bloom periods, muscle concentrations of unbound microcystins in yellow perch are 
likely lower than the recommended limit for chronic exposure.  
Poste et al. [40] also concluded that despite the higher concentration of microcystins measured in 
the muscle tissue of some Great Lakes fish causing individual fish to be of potential human health 
concern, the shorter length of the bloom season, time for elimination and amount of fish consumed 
made it likely that most consumers of Great Lakes fish were not receiving chronic exposure to 
microcystins through fish in excess of the WHO TDI. In contrast, an important finding in a study of 
concentrations of microcystins in fish from lakes in Uganda is that in communities in tropical locations 
with persistent year-round cyanobacterial blooms, which rely on local fish for subsistence and frequently 
consume the entire fish, may be at risk for health risks through chronic microcystin exposure [40].  
3. Experimental Section 
Juvenile yellow perch (Perca flavescens) were used for two uptake and elimination experiments, 
run in June and July 2008. Prior to each experiment, fish 9–14 cm in length were obtained at the 
Stoney Creek Fish Hatchery (Grant, MI) and kept in the dark with Stress Coat
®, a synthetic slime 
coating which helps protect the fish, during the two hour transport to the laboratory. Fish were held at 
20 °C for 24–28 h before the start of the experiment and were fed once.  
Microcystin LR was obtained from Sigma Scientific and stored at −20 °C. The day of the exposure, 
microcystin-LR (MC-LR) was dissolved in 100% methanol (MeOH) to the appropriate concentration, 
added to a food pellet (Zeigler salmon crumbles, Zeigler Bros. Inc. Gardners, PA) by pipette, and 
allowed to dry. Each fish was fed one pellet orally, thus delivering a known dose of MC-LR. Control 
fish were fed a pellet treated with just MeOH and no MC-LR. Fish were observed for 30 min to make 
sure the pellet was not regurgitated. The dose given was 20 µg MC-LR in the June experiment and 5 µg 
MC-LR in the July experiment. Dose concentrations were confirmed by analysis of extra food pellets. 
Water used in all experiment was collected from the Huron River upstream from Dexter, MI at the 
Hudson Mills Metropark. Hardness (165–250 mg L
−1 CaCO3), alkalinity (17–250 mg L
−1 CaCO3) and 
pH (8.1–8.3) were measured before the experiments were performed. Four replicate fish were used for 
each time point and each fish was kept in an individual tank containing 4 L of filtered (0.2 µm filter) 
river water. In order to determine the time points for these experiments, a preliminary experiment was 
run in which the fish were dosed with 5 µg MC-LR, and measurements of microcystin concentrations 
in the liver and muscle were taken out to 240 h (at 2, 4, 8, 12, 24, 48, 72, 120, 168 and 240 h). Based 
on the results of this preliminary experiment, the period from 0–24 h was selected for more detailed 
analysis. At each time point (0, 2, 4, 6, 8, 10, 12, 15, 17, 19, 21, and 24 h), four fish were sacrificed, 
length and wet weight of each fish was recorded, and then liver and muscle tissues were removed for 
microcystin analysis. The entire fillet from each side of the fish was used for the muscle sample and 
the two fillets per fish were analyzed separately. The liver was run as a single sample. To control for 
factors outside dosing with microcystin, there were two sets (4 each) of control fish that were fed 
pellets without MC-LR and then processed in the same manner as the dosed fish; one set was taken for 
analysis at 0 h and the other at 24 h. 
After the fish was removed from its tank at a given time point, the 4 L of tank water was transferred 
to a 4 L bottle and hooked up to a vacuum manifold. To concentrate the dissolved fraction of MC that Mar. Drugs 2011, 9  
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had been excreted by the fish, the water was drop wise siphoned through a 3 cc Oasis HLB type SPE 
column (Waters, Milford, MA) that had been conditioned with 1 mL of 100% MeOH and equilibrated 
with 1 mL nano-pure water. If present, feces were not separated from tank water. The SPE column was 
then washed with 1 mL of 5% MeOH in water and samples were eluted with 100% MeOH, dried 
under vacuum at room temperature and stored at −20 °C.  
Fish tissues (liver, muscle) were freeze dried, weighed, and then extracted in 20 mL of 75% MeOH 
with mastication, using a variation of the method described in Wilson et al. [28]. Samples were 
centrifuged (9000 rpm, 5 min) and the supernatant retained in a clean glass vial. The tissue was 
extracted a second time in 30 mL of 75% MeOH plus 75 μL of acetic acid overnight. Again the sample 
was centrifuged and the supernatant combined with the supernatant from the first extraction, then dried 
under vacuum at room temperature. When dry, the extracted sample was placed under nitrogen, 
capped and stored at −20 °C until analyzed. For microcystin analysis, tissue extracts were rehydrated 
with nano-pure water and sonicated in an ice bath for 30 min to assist in dissolving dried sample. 
Microcystin analysis was by ELISA, according to manufacturer’s instructions (Envirologix, Portland, 
ME). The Envirologix assay uses a polyclonal antibody that detects multiple microcystin variants, with 
varying degrees of cross-reactivity. While the ELISA data is expected to be predominantly MC-LR 
since this is what was dosed into the fish, the ELISA data is expressed as concentration of microcystins 
(MC) to reflect the potential for other variants present. Microcystin-LR loss in the extraction process 
was quantified by measuring recovery of a known concentration of MC-LR spiked into non-dosed 
tissues from fish not included in the experiments. The average for the four fish at each time point was 
divided by the known initial dose delivered through the food pellet to get a percentage of the initial 
dose accounted for at each time point, which would not include microcystins present in the bile, gut, or 
other organs or covalently bound to the liver and muscle tissue.  
The kinetics of the uptake of this single dose of MC-LR and subsequent accumulation in muscle 
and liver over time as measured by immunoassay was modeled and used all available data including 
initial background concentrations. In order to determine the appropriate modeling approach to use, a 
preliminary analysis of the data was conducted. From a kinetic stand point, the exposure is a pulse and 
assumed to decline in a first order manner over time. A plot of the tissue MC concentration over time 
showed an increase to a peak and then a decline that appeared to be first order. Thus, there are three 
variables that affected the concentration of MC in the tissues: the exposure concentration which is 
assumed to decline in a first order manner, the accumulation and distribution of the MC to the tissues, 
and the biotransformation and elimination of MC from the tissue. Since an immunoassay was used for 
the measurements, all the material measured as MC was assumed to be parent compound but may 
include a metabolite(s) that is immunologically active. The approach to modeling the kinetics is 
limited because there are three variables and the tissue concentrations depend on each of those variables, 
so a direct fit was not thought to be the most practical approach to obtaining kinetic estimates. Since 
there is an apparent first order decline in tissue concentration beginning at 10 to 12 h after dosing, the 
declining tissue concentration was fit to a first order loss model (Equation 1) making the assumption 
that uptake was insignificant after that point in time.  
0 e kt Ca Ca e
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Here Ca is the concentration in the tissue (ng g
−1 dw), Ca
0 is the initial concentration in the tissue at 
the beginning of the loss process (ng g
−1 dw), t is time (h) and ke is the elimination rate constant (h
−1).  
The apparent elimination constant determined in this manner was then set as a fixed value and the 
tissue data modeled using a declining source term, as shown in Equation (2): 
 
0 t
ue
dCa
kAe kC a
dt
λ − =−  (2) 
which integrates to Equation (3) and this equation is used to fit the data. 
 
0()
e kt t
u
e
kA e e
Ca
k
λ
λ
− − −
=
−
 (3) 
Here Ca is the concentration in the tissue (ng g
−1 dw), ku is the uptake rate constant (g
−1·h
−1), A
0 is 
the amount of compound dosed to the fish (ng), ke is the elimination rate constant (h
−1) determined 
from equation 1, λ is the loss rate for the dose (h
−1) and t is time (h). For both equations, the data are fit 
using Scientist
® (St. Louis, MO, USA). 
The half life (t0.5) of the MC in each tissue was calculated based on the elimination rate constant  
ke (h
−1) as shown in Equation (4): 
  0.5
ln(2)
e
t
k
=  (4) 
as well as the time in which 95% of the MC is eliminated from the fish tissue, as shown in Equation (5): 
  0.05
ln(20)
e
t
k
=  (5) 
4. Conclusions 
The goal of this study was to determine the rates and time scales of MC-LR uptake and elimination 
in yellow perch to help assess the potential for human exposure to this cyanotoxin through fish 
consumption. The relatively rapid uptake and elimination of the unbound fraction of MC in the liver 
and muscle of juvenile yellow perch within 24 h of oral exposure indicates that fish consumption may 
not be a major route of human exposure to microcystins in the Great Lakes. This efficient elimination 
of MC may also help explain the tolerance of fish to toxic Microcystis blooms, though does not 
eliminate the possibility of chronic impacts to fish health or the risk of bound microcystins in fish 
tissue to human health.  
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